Surgical Management of Distant Melanoma Metastases

ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease Control

“…In the past, conventional systemic therapy using drugs such as dacarbazine and temozolamide resulted in 5-year overall survival (OS) of only 5-6%, 1 and surgery was a reasonable treatment option for carefully selected patients with metastatic melanoma at distant sites, achieving considerably better 5-year OS (up to 40%). 2…”